The Office of Research and Development, Periyar Maniammai Institute of Science & Technology (Deemed to be University), Vallam, Thanjavur 613 403, Tamil Nadu, India.
Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Al-Qara, Abha 61421, Saudi Arabia.
Drug Discov Today. 2023 Jul;28(7):103627. doi: 10.1016/j.drudis.2023.103627. Epub 2023 May 22.
The past couple of decades in particular have seen a rapid increase in the prevalence of type 2 diabetes mellitus (T2DM), a debilitating metabolic disorder characterised by insulin resistance. The insufficient efficacy of current management strategies for insulin resistance calls for additional therapeutic options. The preponderance of evidence suggests potential beneficial effects of curcumin on insulin resistance, while modern science provides a scientific basis for its potential applications against the disease. Curcumin combats insulin resistance by increasing the levels of circulating irisin and adiponectin, activating PPARγ, suppressing Notch1 signalling, and regulating SREBP target genes, among others. In this review, we bring together the diverse areas pertaining to our current understanding of the potential benefits of curcumin on insulin resistance, associated mechanistic insights, and new therapeutic possibilities.
在过去的几十年中,2 型糖尿病(T2DM)的患病率迅速上升,这是一种以胰岛素抵抗为特征的衰弱代谢紊乱。目前针对胰岛素抵抗的管理策略效果不足,需要额外的治疗选择。大量证据表明姜黄素对胰岛素抵抗可能有有益作用,而现代科学为其在疾病防治中的潜在应用提供了科学依据。姜黄素通过增加循环中的鸢尾素和脂联素水平、激活 PPARγ、抑制 Notch1 信号通路以及调节 SREBP 靶基因等方式来对抗胰岛素抵抗。在这篇综述中,我们汇集了与姜黄素对胰岛素抵抗的潜在益处、相关的机制见解和新的治疗可能性相关的各个领域的知识。